ArticleJournal of neuroinflammation2024

Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson's disease.

Jae-Bong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.